>
Switch to:

Eidos Therapeutics Other Stockholders Equity

: $0.00 Mil (As of Sep. 2020)
View and export this data going back to 2018. Start your Free Trial

Eidos Therapeutics's Other Stockholders Equity for the quarter that ended in Sep. 2020 was $0.00 Mil.

Eidos Therapeutics's annual Other Stockholders Equity stayed the same from Dec. 2017 ($0.00 Mil) to Dec. 2018 ($0.00 Mil) but then declined from Dec. 2018 ($0.00 Mil) to Dec. 2019 ($-0.00 Mil).


Eidos Therapeutics Other Stockholders Equity Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Eidos Therapeutics Annual Data
Dec16 Dec17 Dec18 Dec19
Other Stockholders Equity 0.00 0.00 0.00 -0.00

Eidos Therapeutics Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Other Stockholders Equity Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.00 0.00 0.00 0.00

Eidos Therapeutics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Eidos Therapeutics Other Stockholders Equity Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)